- Retrospective cohort of 982 PHN patients: 504 received pulsed radiofrequency and 478 controls received non-PRF management, with propensity overlap weighting for 29 covariates.
- The primary outcome was 12-week treatment success, defined as at least a 2-point drop on an 11-point numeric rating scale.
- Success at 12 weeks was 63.0% with PRF versus 52.1% in controls (doubly robust OR 1.59, 95% CI 1.12-2.25, P = .009).
- Pain reduction at 4 weeks favored PRF but was not sustained; exploratory subgroups suggested better response with dysesthesia and without allodynia.
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
AI summary not available. Read the source abstract on PubMed.
- Systematic review and meta-analysis of five placebo-controlled RCTs (335 participants) testing perioperative pregabalin in adults undergoing elective lumbar spine surgery.
- Pregabalin was compared with placebo, with the primary outcome being pain intensity at 3 months, pooled across four trials (275 participants).
- Pregabalin did not reduce 3-month pain intensity (SMD 0.03, 95% CI -0.41 to 0.47; I² 69%; low certainty).
- Functional disability was lower with pregabalin (SMD -0.51, 95% CI -0.86 to -0.16), but the differences fell below minimal important change thresholds, with very low certainty.
- Retrospective claims cohort using target trial emulation of 5842 adults aged 18-64 with type 2 diabetes and opioid use disorder.
- GLP-1 receptor agonist initiators were compared with initiators of other second-line antidiabetic medications.
- GLP-1 RA initiation was linked to fewer pain-related ED visits (aIRR 0.81; 95% CI 0.69-0.96; P=.01) and the composite outcome (aIRR 0.83; 95% CI 0.72-0.97; P=.02).
- Pain-related hospitalizations did not differ significantly (aIRR 0.92; 95% CI 0.68-1.24; P=.56), and the authors suggest GLP-1 RAs might be repurposed for pain in OUD.
- In vivo electrophysiology and patch-clamp recordings in the spinal dorsal horn of FADS atopic dermatitis model mice compared with healthy controls.
- Spontaneous superficial-layer firing was tested with pharmacologic blockade using CNQX, RC-3095 (GRPR antagonist), and anantin (NPRA antagonist).
- Spontaneous firing was abolished by CNQX but not by RC-3095 or anantin, and FADS neurons showed increased sEPSCs and decreased sIPSCs, with increased GRP and Iba1 mRNA; no effect sizes or p values are given in the abstract.
- The authors conclude that SDH neurons receive glutamate-mediated itch signals and that a shift in excitatory/inhibitory balance may contribute to central sensitization in chronic itch.
- Mixed-methods pilot randomised controlled trial of 24 adults with knee osteoarthritis, combining quantitative feasibility data with semi-structured interviews.
- Participants were assigned to active or sham home-based tDCS plus an eight-week exercise program, with 10 stimulation sessions over two weeks.
- Adherence was high: 21/24 (88%) completed at least 75% of tDCS sessions, and no significant adverse events occurred. Mean pain intensity fell in both groups by week 8, from 47.3 to 28.3 (active) and 46.4 to 33.5 (sham).
- The authors concluded the approach was feasible, acceptable and well tolerated, and that a fully powered trial of 80 participants is warranted to test effects on pain and function.
- A retrospective matched case-control study of over 370,000 database members (2003–2025) compared 1,811 fibromyalgia cases with 8,988 matched controls.
- Exposure was a positive CMV IgM or IgG test, with a two-year washout, and models adjusted for psychiatric, sleep, obesity, and smoking.
- Prior CMV exposure was 50.7% in cases versus 45.6% in controls, with adjusted OR 1.321 (95% CI 1.173–1.488; P < 0.001).
- The association held across stricter case definitions and alternative washout periods, and the authors call for prospective studies to test causality.
AI summary not available. Read the source abstract on PubMed.
- This PRISMA-ScR scoping review screened 2,187 records and included 12 studies of ketamine with pain and depression outcomes assessed longitudinally.
- Eight studies enrolled chronic pain patients and four enrolled depression-primary populations, while acute, perioperative, perinatal, and cancer-related pain were excluded.
- Most studies reported concurrent improvement in pain and depressive symptoms, but the abstract gives no pooled effect size.
- The authors conclude that heterogeneity in populations, dosing, design, and comorbidity prevents inferring that depression modifies ketamine's analgesic effect, and call for randomized trials.
- A 30-day prospective cohort of 53 youths aged 8-18 at a tertiary pediatric headache program recorded 769 headache days via electronic diaries.
- Daily disability (PedMIDAS) was compared with same-day pain catastrophizing, mood, and anxiety, plus mood and anxiety in the 24-48 hours around headache days, using mixed-effects models.
- Higher same-day state catastrophizing (IRR 1.03, 95% CI 1.01-1.05) and lower mood (IRR 0.92, 95% CI 0.87-0.97) were linked to greater headache-day disability, while the anxiety link did not survive multiple-comparison correction.
- Mood and anxiety before and after headache days did not predict disability, suggesting the associations are immediate rather than lagged.
- Qualitative descriptive study of 17 people who had amputation for therapy-resistant CRPS, interviewed at a tertiary expertise center and analyzed by thematic analysis.
- Participants described a narrowing life with severe pain and loss of function, and amputation was considered either electively or as a medical necessity.
- After surgery, experiences varied: some reported pain relief and renewed participation, while others had persistent pain, complications, or difficulties with prostheses.
- Participants judged benefit through function, autonomy, identity, and quality of life, compared with their pre-surgery restrictions, and the authors frame amputation as an irreversible turning point.
- This retrospective observational study reviewed electronic records of 1,015 women with advanced gynecologic cancer and documented pain at a tertiary cancer center in Mexico, 2013–2023.
- Pain was characterized by location, intensity, onset, and type (somatic, visceral, neuropathic, or mixed), with descriptive statistics by tumor type; no intervention was given.
- Pain was mainly pelvic or abdominal (81.0%) and commonly mixed visceral/neuropathic, with median intensity 4/10 and median 7/10 in uterine sarcoma.
- The authors conclude pain is heterogeneous with tumor-type-specific patterns that may guide individualized palliative care, and nearly half of patients had anxiety or depression.
AI summary not available. Read the source abstract on PubMed.
- Secondary analysis of a prospective observational cohort of 562 opioid-naive adults discharged from two urban EDs with a new opioid prescription, with six-month follow-up.
- Exposures were early post-discharge pain frequency and intensity and opioid use at 48 hours and two weeks, compared against new-onset chronic pain at six months.
- Among 483 participants without baseline chronic pain, 129 (26.7%) developed new-onset chronic pain; pain at 48 hours gave OR 2.77 (95% CI 1.40-5.48), attenuating when two-week pain was added.
- Two-week pain frequency (OR 2.36, 95% CI 1.39-4.00) and moderate/severe pain at two weeks (OR 2.20, 95% CI 1.37-3.53) remained associated, while opioid use was not.
- Open-label multicentre randomised trial across 15 UK thoracic centres included 737 adults undergoing thoracotomy in the modified intention-to-treat population.
- The paravertebral group received three single-shot injections before incision plus a catheter, compared with a thoracic epidural catheter loaded with local anaesthetic before incision.
- Chronic post-thoracotomy pain at six months did not differ significantly, at 22% versus 16% (adjusted RR 1.32, 95% CI 0.93 to 1.86, P=0.12).
- Paravertebral blockade had less hypotension (12% vs 18%) and pruritus but more urinary retention (12% vs 6%), and day 1 acute pain was higher with paravertebral blockade.
- Cross-sectional analysis of 2017-2023 MEPS data covering 43,813 children under 18 in the U.S.
- Compared children with treated pain conditions (headache, musculoskeletal, abdominopelvic, menstrual, nervous system pain) against those without, adjusting for covariates.
- Pain was associated with $1,703 higher adjusted medical expenditure per child (95% CI $550-2857, p=0.004), estimated at $6.3 billion annually nationally.
- Pain was linked to higher financial toxicity: 27.3% vs 20.5% subjective burden (aOR 1.3, 95% CI 1.1-1.5) and 7.3% vs 4.2% high objective burden (aOR 1.3, 95% CI 1.0-1.7).
- This is a perspective paper that reviews clinical presentations, presumed mechanisms, and existing guidelines for primary myofascial orofacial pain; it reports no patient sample.
- The authors propose a hypothetical phenotyping framework with four pathophysiological domains: pain mechanisms, psychological distress, functional disability such as limited mouth opening, and oral behaviors.
- They suggest the framework could complement existing classification systems and guide more mechanism-driven management, but state that it requires validation through retrospective, mechanistic, and prospective research.
- This systematic scoping review screened 4,344 records and included 29 unique studies (21 articles and 12 protocols) of mHealth interventions for adults with chronic non-cancer pain.
- Included interventions were mainly mobile apps (n = 14), followed by text messaging (n = 5) and telephone interactive voice response (n = 3).
- Opioid use was an eligibility criterion in 14 studies, and seven were designed specifically to support opioid tapering.
- Published results reported high acceptability and feasibility with potential efficacy, and the authors call for future studies to evaluate efficacy and mediating or moderating factors.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- Randomized controlled trial of 90 healthy female participants, assigned to an open-label placebo group with choice, an open-label placebo group without choice, or a no-placebo control.
- Perceived pain was measured with transcutaneous electrical stimulation at baseline and after open-label placebo treatment or a waiting period.
- Open-label placebo reduced reported pain whether or not participants could choose the placebo type, and the choice group showed no preference for capsules, sprays, or colors.
- Higher positive superstition was linked to greater pain reduction in the placebo groups, while higher reported pain sensitivity showed the opposite pattern.
- This online four-group experiment compared pain-free participants and patients with chronic pain who watched videos of a model receiving pain stimuli with or without placebo.
- Experimental groups had their higher expected-pain ratings reinforced by the experimenter, while control groups received noncontingent reinforcement; modification used verbal modeling of others' lower ratings.
- Online operant conditioning induced nocebo expectancies, which were not reduced by verbal modeling and persisted after 3 days, with no significant differences between chronic pain and pain-free groups.
- The authors suggest brief expert-delivered online feedback may be enough to shape expectancies that resist later modification.
- Case series with narrative review of anterior femoral cutaneous nerve anatomy, injury mechanisms, and management, including two patients.
- Both patients had neuropathic anteromedial thigh pain after femoral catheterization, consistent with intermediate femoral cutaneous nerve involvement, and were treated with ultrasound-guided hydro-dissection.
- Both patients reported sustained symptom resolution at six months.
- The authors conclude that AFCN injury is a treatable, under-recognized complication of femoral access and support targeted hydro-dissection in selected patients.
- This technical report describes an endoscopic thoracic facet joint denervation technique and two patient cases followed by standardized telephone survey.
- The approach targets the inferior-lateral to superior-lateral facet capsule endoscopically, aiming to sever articular branches while sparing the exiting spinal nerve.
- At 13.7 months, one patient's left-sided NRS fell from 9 to 2 and the right from 9 to 7; the other's NRS fell from 9 to 0 at 17.9 months.
- Both patients reported PGIC 7 and satisfaction 5, with no procedural complications, and the authors call for formal evaluation of the strategy.
- Retrospective single-arm cohort of 31 patients (35 knees), mean age 73.6 years, with Kellgren-Lawrence grade 3 or 4 in 91%, treated at a single setting.
- Patients received ultrasound-guided cooled radiofrequency ablation for knee osteoarthritis, with outcomes compared from baseline to 3 months; no control group was included.
- Walking VAS pain fell by 24.0 points and KOOS Pain rose by 12.8 points (p < 0.001), with 42.9% of knees reaching at least a 50% walking-pain reduction.
- The authors concluded that pain and function improved at 3 months without group-level worsening of KL grade, alignment, or bone marrow lesions, and that no serious procedure-related adverse events were recorded.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- A Swedish population-representative survey followed 6328 people over 7 waves spanning 42 years, from ages 15 to 101, with about 25,000 observations.
- Sex-stratified latent class growth analysis grouped participants by musculoskeletal pain severity across sites, from no pain to severe pain in 2 to 3 sites.
- Two trajectories emerged for each sex: a high-risk group whose pain rose through working age and fell after retirement, and a low-pain group whose pain rose only after retirement age.
- The high-risk group was about 20% of women and 9% of men, and the authors attribute the late-life rise to normal ageing and cumulative working-life risk factors.
- This narrative review synthesises mechanistic evidence from human tissue analyses, advanced neuroimaging, and deep clinical phenotyping in entrapment neuropathies, the most prevalent focal neuropathic pain conditions.
- The authors describe these disorders as biologically dynamic, involving microvascular compromise, demyelination, axonal degeneration, immune dysregulation, neuroinflammation, central adaptations, and psychosocial influences.
- Varying combinations of these processes are proposed to explain clinical heterogeneity within one diagnosis and discordances such as normal electrodiagnostic findings or imaging-symptom mismatch.
- The authors argue that surgical decompression offers a natural model of focal nerve injury and that mechanism-informed management may be needed, since one-size-fits-all treatments have largely failed.
- This perspective article proposes a conceptual framework for pediatric chronic pain research and care, rather than reporting new empirical data.
- The BRIDGE framework combines biobehavioral mechanistic research with digital monitoring, such as wearable sensors and ecological momentary assessment, and guided patient engagement.
- The authors argue that these tools could identify modifiable mechanisms, digital biomarkers of risk and recovery, and support precision and adaptive treatment.
- They emphasize that partnership with youth and families is central, so that measurement and interventions stay aligned with patient priorities and lived experience.
- This is a narrative review by a pain researcher accepting a 2026 lifetime achievement prize, summarizing four decades of animal-model work.
- It covers gene expression changes related to neuroplasticity in dorsal root ganglion and spinal cord, using morphological, molecular, behavioral, and electrophysiological methods.
- The abstract reports no quantitative results, effect sizes, or statistics; it describes the scope of the review and planned discussion of methods and future directions.
- This invited viewpoint synthesizes contributors to pain inequity in low- and middle-income countries and among cultural minority groups in high-income settings.
- Proposed remedies include education of health professionals and the public, culturally and linguistically responsive assessment, contextually adapted self-management, and standardized collection of sociodemographic data.
- The author proposes principles for North-South collaboration, including co-created research agendas, shared leadership, sustainable capacity building, and transparent governance.
- The conclusion calls for coordinated action across clinicians, researchers, institutions, policymakers, journals, funders, and communities.
- This article is a discussion piece on neuropathic pain, not a primary study, so it reports no trial data or effect sizes.
- It argues that heterogeneous neuropathic pain mechanisms, not only etiology, may explain repeated trial failures and suggests mechanism-based reclassification.
- It notes that no validated biomarkers for pain mechanisms currently exist, so it discusses surrogate markers such as patient-reported sensory symptoms and sensory testing.
- The authors propose integrating these candidate predictive and surrogate markers into future clinical trials to identify likely treatment responders.
- This narrative review synthesizes work on human nociceptor diversity, linking microneurography, patch-clamp electrophysiology, and single-cell transcriptomics.
- It discusses transferring microneurography hallmarks, such as activity-dependent slowing and recovery cycles, into in vitro patch-clamp paradigms, with Patch-seq assigning molecular identity to functional subtypes.
- The mechano-insensitive 'sleeping' nociceptor is offered as an example of a functionally defined subtype characterized molecularly.
- The authors argue that integrating human nerve fiber function with molecular programs, including sodium channel subtypes, could enable stratified, mechanism-based neuropathic pain therapies.
- This is an updated perspective article reviewing how exercise may act on the mesocorticolimbic system in chronic pain.
- It proposes three routes: myokines such as IGF-1 acting through orexin and VTA dopamine neurons, amygdala circuits, and dorsal raphe serotonin neurons.
- No sample sizes, effect sizes, or confidence intervals are reported, so the supporting evidence is described only qualitatively.
- The authors conclude that exercise therapy should be a key component of chronic pain management, and propose epigenetic changes as a basis for lasting effects.
- This review examines drug combination therapy for pain, drawing on preclinical synergy studies, real-world prescribing data, and many randomized trials across several pain conditions.
- Combining drugs from different mechanistic classes is proposed to give superior analgesia and possibly fewer side effects than monotherapy, based on preclinical synergy.
- Real-world data reportedly show that about half of patients with chronic pain, and more with acute pain, receive two or more drugs from different classes.
- The authors argue that many analgesic combinations lack rigorous evidence and propose five priorities, including trials that compare each monotherapy component.
- This perspective article synthesizes pharmacology, neural recording, and causal manipulation evidence on spontaneous neuropathic pain and presents no original sample or data.
- It describes injured-fiber ectopic activity in specific sensory neuron subtypes as a dominant peripheral generator of spontaneous pain, separate from spared-fiber pathways that drive evoked hypersensitivity.
- The authors argue spontaneous neuropathic pain should be defined as its own symptom domain, because most therapies were validated on evoked or overall intensity endpoints.
- They propose longitudinal, biomarker-informed phenotyping to capture fluctuating pain and support mechanism-based, symptom-aligned treatments.